293780.KQ

AptaBio Therapeutics Inc. [293780.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

293780.KQ Stock Summary

Top 10 Correlated ETFs

293780.KQ


Top 10 Correlated Stocks

293780.KQ


In the News

293780.KQ Financial details

Company Rating
Sell
Market Cap
138.48B
Income
-19.1B
Revenue
323.87M
Book val./share
2436.32
Cash/share
2371.66
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Jan 2023
P/E
-16.63
Forward P/E
-
PEG
-2.06
P/S
3567.74
P/B
4.04
P/C
2.93
P/FCF
-23.12
Quick Ratio
10.11
Current Ratio
13.13
Debt / Equity
0.25
LT Debt / Equity
0.25
-
-
EPS (TTM)
-856.45
EPS next Y
-
EPS next Q
-
EPS this Y
80.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
24.24%
Revenue last 5Y
-20.48%
Revenue Q/Q
3348.52%
EPS Q/Q
99.26%
-
-
-
-
SMA20
-3.2%
SMA50
-22.77%
SMA100
-17.57%
Inst Own
-
Inst Trans
-
ROA
-22%
ROE
-23%
ROC
-0.2%
Gross Margin
91%
Oper. Margin
-19558%
Profit Margin
-22309%
Payout
-
Shs Outstand
22.3M
Shs Float
14.6M
-
-
-
-
Target Price
-
52W Range
4935.0-13650.0
52W High
-49.16%
52W Low
+40.63%
RSI
60.83
Rel Volume
0.71
Avg Volume
150.01K
Volume
106.69K
Perf Week
14.52%
Perf Month
-2.53%
Perf Quarter
-22.28%
Perf Half Y
-23.48%
-
-
-
-
Beta
2.033
-
-
Volatility
322.64%, 653.33%
Prev Close
-2.39%
Price
6940
Change
2.81%

293780.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
46.815.4814.892.1714.52
Net income per share
-289.38-177.89-711.76-473.98-856.45
Operating cash flow per share
-275.78-171.83-592.45-306.55-632.1
Free cash flow per share
-447.61-266.09-603.71-359.78-639.61
Cash per share
2.12K1.94K1.53K762.482.37K
Book value per share
3.45K3.27K4.11K2.35K2.44K
Tangible book value per share
3.45K3.27K4.1K2.35K2.44K
Share holders equity per share
3.45K3.27K4.11K2.35K2.44K
Interest debt per share
1.261.293.765.12667.45
Market cap
879.24B889.99B558.66B231.81B202.47B
Enterprise value
862.73B875.37B552.2B229.19B190.39B
P/E ratio
-139.61-227.1-52.26-21.94-10.6
Price to sales ratio
863.212.61K2.5K4.79K625.17
POCF ratio
-146.49-235.11-62.79-33.93-14.36
PFCF ratio
-90.26-151.83-61.62-28.91-14.2
P/B Ratio
11.712.359.064.433.73
PTB ratio
11.712.359.064.433.73
EV to sales
8472.57K2.47K4.74K587.87
Enterprise value over EBITDA
-122.28-151.02-50.1-25.4-11.63
EV to operating cash flow
-143.74-231.25-62.06-33.54-13.51
EV to free cash flow
-88.56-149.33-60.91-28.58-13.35
Earnings yield
-0.010-0.02-0.05-0.09
Free cash flow yield
-0.01-0.01-0.02-0.03-0.07
Debt to equity
00000.25
Debt to assets
00000.15
Net debt to EBITDA
2.342.520.590.290.74
Current ratio
63.9954.630.1919.6370.27
Interest coverage
-3.52K-2.63K-6.19K-2.11K-14.26
Income quality
0.950.970.830.650.74
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.050.170.362.090
Research and developement to revenue
5.3611.2340.59128.1638.23
Intangibles to total assets
00000
Capex to operating cash flow
0.620.550.020.170.01
Capex to revenue
-3.67-6.09-0.76-24.53-0.52
Capex to depreciation
-39.16-8.31-0.53-2.58-0.33
Stock based compensation to revenue
0.480.530.612.560
Graham number
4.74K3.62K8.11K5.01K6.85K
ROIC
-0.1-0.08-0.18-0.18-0.32
Return on tangible assets
-0.08-0.05-0.16-0.19-0.21
Graham Net
2.03K1.81K1.33K699.98754.28
Working capital
46.04B42.94B22.99B19.38B56.66B
Tangible asset value
75.14B71.99B61.62B52.33B54.33B
Net current asset value
44.52B40.34B20.53B16.67B19.28B
Invested capital
00000.25
Average receivables
0522.57M601.52M1.82B2.98B
Average payables
00000
Average inventory
0000.50.5
Days sales outstanding
122.82751.73816.9723.66K3.19K
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
2.970.490.450.020.11
Payables turnover
00000
Inventory turnover
00011.15M0
ROE
-0.08-0.05-0.17-0.2-0.35
Capex per share
-171.83-94.26-11.26-53.22-7.51

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.80.870.30.3812.97
Net income per share
-115.11-200.39-96.51-186.98-372.57
Operating cash flow per share
-89.76-138.36-57.25-79.6-356.89
Free cash flow per share
-111.9-140.54-59.69-86.05-353.33
Cash per share
762.16513.05843.673.11K2.37K
Book value per share
2.35K2.15K2.05K2.87K2.44K
Tangible book value per share
2.35K2.15K2.05K2.87K2.44K
Share holders equity per share
2.35K2.15K2.05K2.87K2.44K
Interest debt per share
55.345.13765.61651.85
Market cap
231.91B229.9B199.8B206.71B202.47B
Enterprise value
229.29B223.88B194.11B190.08B190.39B
P/E ratio
-22.59-12.86-23.21-12.39-6.09
Price to sales ratio
12.96K11.8K29.45K24.65K700.09
POCF ratio
-115.87-74.52-156.51-116.45-25.44
PFCF ratio
-92.94-73.36-150.1-107.73-25.7
P/B Ratio
4.434.794.373.233.73
PTB ratio
4.434.794.373.233.73
EV to sales
12.82K11.49K28.61K22.67K658.32
Enterprise value over EBITDA
-90.43-64.67-67.66-46.54-32
EV to operating cash flow
-114.56-72.57-152.06-107.09-23.92
EV to free cash flow
-91.89-71.44-145.82-99.07-24.16
Earnings yield
-0.01-0.02-0.01-0.02-0.04
Free cash flow yield
-0.01-0.01-0.01-0.01-0.04
Debt to equity
0000.260.25
Debt to assets
0000.170.15
Net debt to EBITDA
1.031.741.984.072.03
Current ratio
19.6313.1315.6521.9570.27
Interest coverage
-1.58K-1.21K-1.05K-12.3-7.27
Income quality
0.780.690.590.430.96
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.731.63000
Research and developement to revenue
92.1131.43260.38389.3416.55
Intangibles to total assets
00000
Capex to operating cash flow
0.250.020.040.08-0.01
Capex to revenue
-27.6-2.5-8.04-17.130.27
Capex to depreciation
-3.93-0.36-0.44-1.170.64
Stock based compensation to revenue
1.721.87000
Graham number
2.47K3.12K2.11K3.48K4.52K
ROIC
-0.05-0.07-0.06-0.05-0.19
Return on tangible assets
-0.05-0.09-0.04-0.04-0.09
Graham Net
699.69441.38737.661.54K754.28
Working capital
19.38B13.75B20.15B68.72B56.66B
Tangible asset value
52.33B47.98B45.74B64.03B54.33B
Net current asset value
16.67B10.92B17.24B35.11B19.28B
Invested capital
0000.260.25
Average receivables
2.48B3.14B2.85B2.53B2.67B
Average payables
00000
Average inventory
0.510.500
Days sales outstanding
15.77K14.54K33.9K26.95K882.2
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
0.010.01000.1
Payables turnover
00000
Inventory turnover
1.21M3.75M000
ROE
-0.05-0.09-0.05-0.07-0.15
Capex per share
-22.14-2.18-2.45-6.443.56

293780.KQ Frequently Asked Questions

What is AptaBio Therapeutics Inc. stock symbol ?

AptaBio Therapeutics Inc. is a KR stock and trading under the symbol 293780.KQ

What is AptaBio Therapeutics Inc. stock quote today ?

AptaBio Therapeutics Inc. stock price is $6940 today.

Is AptaBio Therapeutics Inc. stock public?

Yes, AptaBio Therapeutics Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks